The People Behind the Mission

The Jewish SLC1A4 Initiative is driven by families who refuse to accept the status quo, and supported by researchers and advisors who believe a treatment is within reach.

Joshua Mirkin, MD
Joshua Mirkin, MD
Co-Founder

Josh is Molly's father and a founding driver of the Jewish SLC1A4 Initiative. After Molly's diagnosis, he committed to advancing towards a treatment for SLC1A4. Josh is an emergency medicine physician.

👩
Jenny Mirkin, PhD
Co-Founder

Jenny is Molly's mother and co-founder of the Initiative. She has a PhD in education and has a background in strategic planning and Jewish initiatives.


Wendy Chung
Wendy Chung, MD, PhD
Scientific Advisor

Dr. Chung discovered SLC1A4 Deficiency and the causative gene. She is the Chief of the Department of Pediatrics at Boston Children's Hospital.

Matthew Anderson
Matthew Anderson, MD, PhD
Scientific Advisor

Dr. Anderson is the Co-director of the Oxford-Harrington Rare Disease Centre.


Greg Nafte
Greg Nafte
Founder of Rare Alliance

Father of a child with SLC1A4 Deficiency and founder of Rare Alliance.

Want to Get Involved?

Whether you are a researcher, clinician, community leader, or simply someone who cares — there is a place for you in this effort.

Join the Initiative